Investors continue to channel capital into Egyptian start-ups addressing critical infrastructure and healthcare needs, even as venture financing across Africa has become increasingly selective. The latest investments in logistics company Mylerz and molecular diagnostics developer Reme-D underscore sustained appetite for businesses with proven market demand and clear paths to revenue generation. According to Africa: The Big Deal, Egypt attracted about $327 million in disclosed startup funding during the first half of 2026—the highest total among African markets—reinforcing the country’s position as one of the continent’s leading venture-capital destinations.
E-commerce fulfilment and last-mile delivery company Mylerz secured more than $2 million (over EGP100 million) through a combination of equity and credit facilities led by existing investor Lorax Capital Partners, with participation from payments technology company Fawry and other shareholders.
The Cairo-based company said the proceeds would strengthen working capital and support the expansion of its warehousing, fulfilment and delivery network across Egypt, including new logistics capacity outside the capital. The financing follows the company’s $9.6 million funding round in 2022, reflecting continued investor confidence in Egypt’s expanding e-commerce infrastructure.
Separately, healthtech company Reme-D completed a $1.45 million pre-Series A funding round led by Anara Impact Capital, alongside Global Innovation Fund, Africa Health Ventures and other investors.
Reme-D develops locally manufactured molecular diagnostic kits for diseases including tuberculosis, HIV, hepatitis and human papillomavirus (HPV). The company plans to expand production capacity, increase exports across African markets and accelerate development of new diagnostics for cancer and genetic disorders.
Although modest by global venture-capital standards, the two transactions are significant in today’s more disciplined African investment environment, where investors increasingly favour companies demonstrating operational execution, sustainable revenues and clear expansion opportunities over speculative growth.
“The investment environment has become markedly more selective, with capital increasingly concentrated in startups that can demonstrate strong fundamentals and measurable business performance,” said Philip Bahoshy, chief executive of Magnitt, describing the broader investment trend across the Middle East and Africa.
Together, the investments highlight two structural themes reshaping Egypt’s start-up ecosystem. Mylerz is expanding logistics infrastructure that supports the country’s growing e-commerce market, while Reme-D is advancing domestic production of sophisticated medical diagnostics, supporting import substitution and improving access to affordable healthcare technologies across Africa.
The transactions also illustrate how investor priorities continue to evolve. Rather than pursuing growth at any cost, venture capital is increasingly backing businesses solving tangible infrastructure and healthcare challenges—companies capable of delivering sustainable returns while strengthening Egypt’s position as a regional innovation hub and a gateway for technology-led expansion across Africa.
Related news:
Egypt Launches National Startup Charter to Mobilise $1bn in Investment
Egyptian Startups Attract $614mn in 2025 as Government Prepares New Incentives
Reme-D Raises $500,000 to Scale Affordable PCR Diagnostics
Read also:
AI Language Models Could Improve the Reliability of Economic Policy Analysis, ECES Study Suggests
BlackRock Becomes First Asset Manager to Surpass $15 Trillion
